Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$2.99 - $3.58 $564,221 - $675,556
-188,703 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$2.9 - $3.3 $1.16 Million - $1.32 Million
-400,794 Reduced 67.99%
188,703 $557,000
Q3 2020

Nov 13, 2020

SELL
$3.14 - $3.48 $273,478 - $303,090
-87,095 Reduced 12.87%
589,497 $1.89 Million
Q2 2020

Aug 13, 2020

SELL
$3.17 - $4.01 $732,723 - $926,883
-231,143 Reduced 25.46%
676,592 $2.25 Million
Q1 2020

May 14, 2020

BUY
$3.45 - $5.33 $39,899 - $61,641
11,565 Added 1.29%
907,735 $3.3 Million
Q4 2019

Feb 13, 2020

BUY
$4.68 - $5.79 $167,174 - $206,824
35,721 Added 4.15%
896,170 $4.62 Million
Q3 2019

Nov 13, 2019

SELL
$4.73 - $6.4 $53,510 - $72,403
-11,313 Reduced 1.3%
860,449 $5.1 Million
Q2 2019

Aug 13, 2019

SELL
$5.35 - $6.8 $1.77 Million - $2.25 Million
-330,213 Reduced 27.47%
871,762 $5.55 Million
Q1 2019

May 14, 2019

SELL
$5.06 - $6.5 $563,957 - $724,451
-111,454 Reduced 8.49%
1,201,975 $6.98 Million
Q4 2018

Feb 13, 2019

BUY
$5.31 - $7.0 $504,598 - $665,196
95,028 Added 7.8%
1,313,429 $7.92 Million
Q3 2018

Nov 13, 2018

BUY
$5.5 - $6.3 $82,841 - $94,890
15,062 Added 1.25%
1,218,401 $6.96 Million
Q2 2018

Aug 14, 2018

SELL
$5.91 - $6.9 $707,438 - $825,943
-119,702 Reduced 9.05%
1,203,339 $7.38 Million
Q1 2018

May 14, 2018

BUY
$6.62 - $7.12 $106,780 - $114,845
16,130 Added 1.23%
1,323,041 $8.84 Million
Q4 2017

Feb 13, 2018

BUY
$6.79 - $7.96 $235,748 - $276,371
34,720 Added 2.73%
1,306,911 $9.62 Million
Q3 2017

Nov 13, 2017

BUY
$6.47 - $7.21 $1.05 Million - $1.18 Million
163,024 Added 14.7%
1,272,191 $8.98 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,109,167
1,109,167 $7.76 Million

Others Institutions Holding CPIX

About CUMBERLAND PHARMACEUTICALS INC


  • Ticker CPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 14,661,900
  • Market Cap $38.9M
  • Description
  • Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...
More about CPIX
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.